Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Was the ruling positive? negative? still undeterminable?

Read a message board, and you'll find all three views. IMO, I suspect it's still undeterminable as this point.

Should existing shareholders and potential investors believe those who have spun it as a 9 out of 10 win?

Should existing shareholders and potential investors believe those who have spun it as the beginning of the end of the MMP?

Should existing shareholders and potential investors believe there is still much to be decided that could still turn things either direction.

In my opinion, the company should at the least, INFORM SHAREHOLDERS that the Markman was issued, and that one of the three scenarios applies. Leaving a vacuum for total speculation about what the ruling means, is unconscionable IMO.

Furthermore, there are factors that could keep the final claim from ever being contrued. Considering where things are, a settlement at this point leaves that issue forever unresolved. We know Leckrone would rather always sell short for sure money than go the distance, even for big money. Time will tell, but hiding in the PTSC office is not only not a strategy, it's a dereliction of their duty to keep shareholders informed of major company developments.

Share
New Message
Please login to post a reply